在过去的十年中,对抑郁症的埃斯基坦胺的研究趋势:一本图书法分析分析
Baozhou Zhang1,2, Yifan Liu1,2, Jinwei Zheng1
1Department of Anesthesiology, Ningbo No.2 Hospital, Ningbo, Zhejiang, China.
Frontiers in psychiatry
|July 10, 2025
概括
图书统计分析显示,对抑郁症治疗的埃斯基他胺研究激增,重点是长期的安全性. 全球研究差异仍然存在,这突出了埃斯基坦胺疗效研究未来发展的领域.
科学领域:
- 药理学和精神病学 药理学和精神病学
- 图书统计分析 图书统计分析
- 心理健康研究趋势
背景情况:
- 抑郁症的特点是持续的低情绪和无情感,造成安全风险,包括自杀念头.
- 埃斯凯特胺在抑郁症治疗中表现有前途,需要对其疗效和安全性进行全面研究.
研究的目的:
- 为了进行对抑郁症治疗中埃斯基他胺的文献分析.
- 调查这个领域的演变,并确定未来的研究轨迹.
主要方法:
- 使用Excel,VOSviewer和CiteSpace软件进行了图书统计分析.
- 生成网络可视化,用于对文学趋势和边界进行定量评估.
主要成果:
- 从2015年到2024年,出版物数量显著增加 (925篇文章),到2024年将达到286篇.
- 美国,中国和加拿大在出版物方面处于领先地位;顶级期刊包括"情感障碍杂志"和"精神病学的边界".
- 关键的作者包括麦金泰尔,RS;哈西莫托,K;罗森布拉特,JD. 关键词:"耐治疗抑郁症"",有效性"",抗抑郁药"",自杀念头".
结论:
- 对治疗抑郁症的胺胺的研究正在迅速扩大,主要关注的是长期的安全性.
- 高收入国家和低收入和中等收入国家之间研究资源的显著差异仍然是一个关键的挑战.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
185
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
12.2K
相关概念视频
Electroconvulsive Therapy
200
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
200
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
Antidepressant Drugs: MAOIs and Other Agents
373
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
373
Antidepressant Drugs: Overview
786
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
786
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
609
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
609
Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107
